Michael Deininger - Böcker
Visar alla böcker från författaren Michael Deininger. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
872 kr
Skickas inom 10-15 vardagar
Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and trends in the treatment of CML and provides an authoritative and convenient summary of the latest progress in imatinib trials, the molecular monitoring of CML responses, and the engineering of new therapies to overcome resistance and improve patient care.Providing critical insight and exploration of models that will enhance the cancer community at large, this source:stands as the only source to focus on post-Gleevec developments in CML therapeuticscollects information from the forefront of the field—helping busy clinicians make informed management decisionssupplies critical research from recognized opinion leaders on the topicprovides an overview of the current status of new transplant modalitiescontains a vivid selection of color photographs
1 196 kr
Tillfälligt slut
Hematology Board Review: Blueprint Study Guide and Q&A is a concise, outline-based study guide covering all topics that appear on the Hematology Certification Exam. The book includes all topics listed in the American Board of Internal Medicine (ABIM) blueprint as essential material for the exam and highlights topic areas that are often found on the test.For hematology and oncology fellows as well as practicing clinicians needing a refresher before taking MOC, this handy study guide provides succinct overviews of all blood disorders, syndromes and diseases with practice questions on the go. Each disorder or disease-based chapter provides the same structure for ease of use beginning with the epidemiology, and followed by the etiology and risk factors, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. The authors provide the most accurate and up-to-date information, including well-established treatment regimens for a variety of blood disorders, including iron disorders, bone marrow failure syndromes, platelet and megakaryocytic disorders, hemostasis, thrombosis, and hematologic malignancies. Later chapters review other major subspecialty areas found on the exam including transfusion medicine and hematopoietic cell transplantation. With 200 board-style questions and answers with detailed rationales, Hematology Board Review is the go-to, quick review for any trainee preparing for initial certification and for hematologists or oncologists preparing for recertification.Key Features:Includes 200 board-style questions and answers with rationalesProvides key point summaries of each topic area for quick study and easy recallThorough coverage of hematologic malignancies, blood disorders, transfusion medicine, hematopoietic cell transplantation, and standard treatment regimensTables providing key data and information related to staging, treatment options, and disease classifications
779 kr
Tillfälligt slut
Chronic Myeloid Leukemia (CML) remains a key model for the improved understanding of the pathophysiology of a malignancy at a molecular level and has been used by researchers to develop a variety of therapies and therapeutic assessment methods. This concise, readable guide assembles and synthesizes the latest developments and trends in the treatment of CML and provides an authoritative and convenient summary of the latest progress in imatinib trials, the molecular monitoring of CML responses, and the engineering of new therapies to overcome resistance and improve patient care.Providing critical insight and exploration of models that will enhance the cancer community at large, this source:stands as the only source to focus on post-Gleevec developments in CML therapeuticscollects information from the forefront of the field—helping busy clinicians make informed management decisionssupplies critical research from recognized opinion leaders on the topicprovides an overview of the current status of new transplant modalitiescontains a vivid selection of color photographs